Proteomics

Dataset Information

0

Pathological pathways and biomarker in Mucolipidosis type IV mice and post mortem patient.

ABSTRACT: In this study we present data from the only available post-mortem mucolipidosis type IV (MLIV) patient. We characterise the brain pathology of the MLIV patient and compare it to pathology from the mice model of MLIV. Moreover, we characterise the proteins found in the MLIV patient CSF and compare it to the mice MLIV CSF. We define possible biomarkers for this devastating disease.

INSTRUMENT(S):

ORGANISM(S): Mus Musculus (mouse)

TISSUE(S): Cerebrospinal Fluid

SUBMITTER: Amir Prior  

LAB HEAD: Anthony H. Futerman

PROVIDER: PXD020490 | Pride | 2021-08-10

REPOSITORIES: Pride

Json Xml

Dataset's files

Source:
Action DRS
Apply_FDR__SP_11.finished.txt Txt
Applying_FDR11.finished.txt Txt
Assembling_proteins0129.finished.txt Txt
Assembling_proteins0229.finished.txt Txt
Assembling_proteins0329.finished.txt Txt
Items per page:
1 - 5 of 2033
altmetric image

Publications

Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways.

Vardi Ayelet A   Pri-Or Amir A   Wigoda Noa N   Grishchuk Yulia Y   Futerman Anthony H AH  

Orphanet journal of rare diseases 20210121 1

<h4>Background</h4>Mucolipidosis type IV (MLIV), an ultra-rare neurodevelopmental and neurodegenerative disorder, is caused by mutations in the MCOLN1 gene, which encodes the late endosomal/lysosomal transient receptor potential channel TRPML1 (mucolipin 1). The precise pathophysiogical pathways that cause neurological disease in MLIV are poorly understood. Recently, the first post-mortem brain sample became available from a single MLIV patient, and in the current study we performed mass spectro  ...[more]

Similar Datasets

Proteomics Pathological pathways and biomarker in Mucolipidosis type IV mice and post mortem patient.
2021-08-10 | PXD020494 | Pride
Proteomics Pathological pathways and biomarker in Mucolipidosis type IV mice and post mortem patient.
2021-08-10 | PXD020491 | Pride
Transcriptomics Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways
2021-01-27 | GSE157825 | GEO
Transcriptomics Gene expression profile in individuals affected by Mucolipidosis type IV
2008-02-11 | GSE5444 | GEO
Transcriptomics Gene expression profile in individuals affected by Mucolipidosis type IV
2010-05-26 | E-GEOD-5444 | biostudies-arrayexpress
Proteomics Novel phenotypical and biochemical findings in mucolipidosis type II
2025-05-07 | PXD060270 | Pride
Genomics The Natural History of Mucolipidosis Type IV - LDN 6704
| PRJNA378815 | ENA
Proteomics Targeting low levels of MIF expression as a potential therapeutic strategy for ALS
2024-05-03 | PXD046619 | Pride
Genomics Proteomics analysis of a human brain sample from a mucolipidosis type IV patient reveals pathophysiological pathways
| PRJNA662921 | ENA
Genomic The Natural History of Mucolipidosis Type IV
| phs001329 | dbGaP